Is Nonsmall Cell Type High-grade Neuroendocrine Carcinoma of the Tubular Gastrointestinal Tract a Distinct Disease Entity?
Jinru Shia(Memorial Sloan Kettering Cancer Center), David S. Klimstra(Memorial Sloan Kettering Cancer Center), Volkan Adsay(Emory University), José G. Guillem(Memorial Sloan Kettering Cancer Center), Leonard B. Saltz(Roswell Park Comprehensive Cancer Center), Baruch Brenner, R. Landmann(Johns Hopkins University), Deepti Dhall, David P. Kelsen(Memorial Sloan Kettering Cancer Center), Philip B. Paty(Memorial Sloan Kettering Cancer Center), Edward B. Stelow(University of Virginia), Jing Qin(National Institute of Allergy and Infectious Diseases), Gregory D. Leonard(Memorial Sloan Kettering Cancer Center), W. Douglas Wong(Memorial Sloan Kettering Cancer Center), Martin R. Weiser(Memorial Sloan Kettering Cancer Center), Larissa K. Temple(Memorial Sloan Kettering Cancer Center), Laura H. Tang(Memorial Sloan Kettering Cancer Center)
Cited by 175
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k